Allied Market Research is a global market research and business consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of “Market Research Reports” and “Business Intelligence Solutions”.
Regenerative Medicine explore new therapies using stem cells research & nanotechnology
Regenerative medicines and associated therapies can help mammalian cells to reconstruct: reconstruction of lost limbs, human cells, tissues and tendons, or even undo organ problems. Regenerative medicines have emerged as a promising field of tissue engineering and refers to the practice of providing treatments to repair, regenerate, and replace damaged cells and tissue. The numerous applications include offering therapies for complex diseases such as Alzheimers and spinal injuries or providing cures for chronic ones like cancer and diabetes. The trend of restoring damaged tissues is evident in spray-on skin and lab-grown ears, with the terms tissue engineering and regenerative medicine used interchangeably.
The benefits of regenerative medicines seemingly extend over medical applications to non-therapeutic ones such as biosensors which are employed to detect biological or chemical threat agents, or biomaterial chips that can assess the toxic effects of a medication. One of the main goals of this emerging field is to improve people’s quality of life and restoring them back to a normal functional state.
Researchers world have already been experimenting with stem cells for long. These progenitor cells can develop into several types of tissue, thereby driving the bodies to heal themselves. Some of the early and most promising clinical trials involved treating congestive heart diseases and regrowing muscles in soldiers who were severely wounded in war. Advances in stem cells especially related to pluripotent cells to treat various regenerative disorders focuses on stem cells that can turn into any kind of cell and is a key factor triggering the growth of the regenerative medicines market.
Regenerative medicines evolving as a multidisciplinary field of biomaterials incorporates nanotechnology as a potent tool to produce material structures that mimic the biological ones capable of providing very efficient delivery systems. The fabrication of materials, such as nanoparticles and scaffolds used for tissue engineering, and the nanopatterning of surfaces can help get “in vivo” in response to the biological signals mammalian cells receive from the surroundings. The applications of stem cells to harness the power of regenerative medicines for curing diseases such as frontotemporal dementia and amyotrophic lateral sclerosis (ALS) look for collaborative findings to help researchers to discover new approaches. Last month, two collaborative teams within USC Stem Cell bagged an award Audrey E. Streedain Regenerative Medicine Initiative Awards. The magnanimous award which summed up to $140,000 each support faculty members affiliated to USC who is keen on multi-investigator research collaborations with the goal of curing diseases using stem cells as potent tools. The eminent researchers Justin Ichida and Paula Cannon, with Department of Stem Cell Biology and Regenerative Medicine, aim to develop a powerful technique for which can help to rectify a gene mutation responsible for 10 % of all cases of ALS & frontotemporal dementia . According to Cannon “These grants are pretty unique in that they allow the type of high-risk research that isn’t feasible without collaboration,”
Various alliances have cropped up recently this year that hope to the bridge the gap between the academia and industry so that the ongoing R&D activities can translate to effective patient care using regenerative medicine.
The Rare Disease Clinical and Patient Education Roundtable which took place on 27th January in Washington is focused on educating multi-sector stakeholders regarding the growth prospects of regenerative medicine market and large scale applications to cure various rare diseases. The event, first of its kind, is announced by the Alliance for Regenerative Medicine (ARM), an international organization representing the researches on gene therapy, cell therapy and tissue engineering. Such collaborations and joint events will tend to increase in future, as the technology progresses and results of cutting-edge research and clinical trials are made public. No doubt, dominant strategy adopted by companies is approval required to initiate clinical trials, continuation of trials and for the commercialization of these therapies. As per a recent report by Allied Market Research gene therapies are expected to be the fastest emerging technology, growing at a CAGR of 28.6% during 2014-2020 forecast period.
A system that gives information and locates the food ingredient or path of food product or throughout food supply chain is called as food traceability system AMR’s new study observed that the market for food traceability will reach a mark of $14.1 billion by 2020 growing at a CAGR of 8.7%. Due to real time locating of food irrespective of place of weather conditions, RFID is calculated to grow at rate of 19.4%. Further, its read-write accuracy in complex environment gives it an upper edge over the other technologies. Food traceability is becoming a norm for all food producers across the globe due to rising consumer demand for food safety coupled with increased government regulation for the same. There has been good market revenue for it in Australia, U.S and Japan due to early adoption of food traceability technology. But due to increased globalization of food market, there lies greater opportunity for food traceability market in developing countries. High cost of investment for this mar…
Over the past few years medical sensors have become smaller. The MEMS (or Microelectrical-mechanical systems) have been popular in medical equipment, from stents to chemosensor. Even the capsule endoscopy systems comes with a miniature camera as well as radio technologies. These systems captures the images of human digestive tract from the inside. Latest discoveries in the data analytics, material science and equipment engineering collectively promise a much smaller and modish sensor. The recent development in miniaturization assures biocompatibility. Medical experts believe that the smaller the system, the less likely it would interfere with the immune mechanism. This is true for capsule endoscopy used to take images of the entire gastrointestinal tract. PillCam® SB launched by Covidien boasts of vitamin –sized, wireless pill design that can improve the diagnosis for small bowel diseases. Recently, a Vanderbilt University engineer, Pietro Valdastri received $1.5 million as grant to c…
elements in presently used honeycomb sandwich material to add structural
strength yields fresh possibilities. Honeycomb sandwich
materials: industry beats
The latest entrant among sandwich panels, where thermoplastic
polymer honeycomb structure meets metal end-sheets is setting serious market
trends. ThermHex’s patented thermoplastic honeycomb core structure, laminated
with aluminum skins, has all desired mechanical properties, minus a
fifty-percent of its previous weight with usual heavy polymer. Realizing market
potential for the technology, TATA Steel announced the launch of Coretinium,
under a license agreement with EconCore, for construction and transportation
recent news, EconCore and DuPont also announced collaborative development
of panels with ultra-light cores. Commendable material transformation by DuPont
have enabled customer-centric customization in these panels.
The much sought after technology, which allows continuous
and efficient pr…